Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19196566 | IDENTIFICATION OF METABOLITES FOR DIAGNOSIS AND TREATMENT FOR SLEEP APNEA | May 2025 | June 2025 | Allow | 2 | 0 | 0 | No | No |
| 19063118 | SYSTEMS AND METHODS FOR GENERATING DROPLETS AND PERFORMING DIGITAL ANALYSES | February 2025 | August 2025 | Allow | 6 | 1 | 0 | Yes | No |
| 19026954 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | January 2025 | April 2025 | Allow | 3 | 0 | 0 | No | No |
| 19013863 | METHODS FOR DETECTING AAV | January 2025 | March 2025 | Allow | 3 | 0 | 0 | No | No |
| 18957846 | URINE TEST DEVICE FOR TOILET AND ITS CONTROL METHOD | November 2024 | September 2025 | Abandon | 9 | 1 | 0 | No | No |
| 18948248 | SYSTEMS AND METHODS FOR GENERATING DROPLETS AND PERFORMING DIGITAL ANALYSES | November 2024 | December 2024 | Allow | 1 | 0 | 0 | Yes | No |
| 18894924 | HYDROGEL PARTICLES AS FEEDER CELLS AND AS SYNTHETIC ANTIGEN PRESENTING CELLS | September 2024 | April 2025 | Allow | 7 | 2 | 0 | Yes | No |
| 18841398 | METHOD FOR SYNCHRONOUS AND FAST DETERMINATION OF TOTAL ARSENIC AND CONTENTS OF ARSENIC METABOLITES IN URINE | August 2024 | August 2025 | Abandon | 12 | 1 | 0 | No | No |
| 18768028 | LUMINESCENT PROBE AND ITS PREPARATION METHOD AND APPLICATION | July 2024 | February 2025 | Allow | 8 | 1 | 1 | No | No |
| 18750532 | LIQUID CHROMATOGRAPHY- MASS SPECTROMETRY (LC-MS) METHODS FOR ANALYZING AMPHOLYTE LOT VARIATION | June 2024 | February 2025 | Allow | 8 | 0 | 0 | Yes | No |
| 18737836 | PSEUDO-ELECTROPHEROGRAM CONSTRUCTION FROM PEPTIDE LEVEL MASS SPECTROMETRY DATA | June 2024 | February 2025 | Allow | 9 | 0 | 0 | No | No |
| 18646572 | SYSTEMS AND METHODS FOR GENERATING DROPLETS AND PERFORMING DIGITAL ANALYSES | April 2024 | December 2024 | Allow | 8 | 0 | 0 | Yes | No |
| 18644592 | REAGENTS AND METHODS FOR ELEMENTAL MASS SPECTROMETRY OF BIOLOGICAL SAMPLES | April 2024 | February 2025 | Allow | 10 | 1 | 0 | No | No |
| 18641661 | Method for full Os isotope static measurement at low-content/small-size sample | April 2024 | February 2025 | Allow | 10 | 0 | 0 | No | No |
| 18698885 | HIGH TEMPERATURE HIGH PRESSURE ASPHALTENE DEPOSITION/INHIBITOR SCREENING TEST | April 2024 | August 2024 | Allow | 4 | 1 | 0 | Yes | No |
| 18615536 | Method and System for Solventless Calibration of Volatile or Semi-Volatile Compounds | March 2024 | December 2024 | Allow | 9 | 1 | 0 | No | No |
| 18606701 | SYSTEM AND METHOD FOR PROTEIN CORONA SENSOR ARRAY FOR EARLY DETECTION OF DISEASES | March 2024 | October 2024 | Allow | 7 | 0 | 0 | No | No |
| 18691905 | METHOD FOR INCREASING NUMBER OF PROTEINS IDENTIFIED BY MASS SPECTROMETRY | March 2024 | January 2025 | Allow | 10 | 2 | 0 | Yes | No |
| 18603030 | DETERMINISTIC RATCHET FOR SUB-MICROMETER BIOPARTICLE SEPARATION | March 2024 | August 2025 | Abandon | 17 | 2 | 0 | Yes | No |
| 18590471 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | February 2024 | November 2024 | Allow | 8 | 1 | 0 | No | No |
| 18417986 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | January 2024 | April 2024 | Allow | 3 | 0 | 0 | No | No |
| 18543524 | DETERMINATION OF ANTIDEPRESSANTS BY MASS SPECTROMETRY | December 2023 | July 2025 | Allow | 19 | 3 | 0 | Yes | No |
| 18514204 | APPARATUS AND METHODS FOR SAMPLE ACQUISITION | November 2023 | March 2025 | Allow | 16 | 0 | 0 | No | No |
| 18388047 | CAPILLARY BARRIERS FOR STAGED LOADING OF MICROFLUIDIC DEVICES | November 2023 | April 2025 | Allow | 17 | 1 | 1 | Yes | No |
| 18386107 | HYDROGEL PARTICLES AS FEEDER CELLS AND AS SYNTHETIC ANTIGEN PRESENTING CELLS | November 2023 | August 2024 | Allow | 9 | 2 | 1 | Yes | No |
| 18496681 | LIGHT ENERGY FLUORESCENCE EXCITATION | October 2023 | September 2025 | Allow | 23 | 3 | 1 | Yes | Yes |
| 18491399 | INLET INSTRUMENTATION FOR ION ANALYSER COUPLED TO RAPID EVAPORATIVE IONISATION MASS SPECTROMETRY ("REIMS") DEVICE | October 2023 | January 2026 | Abandon | 27 | 2 | 0 | No | No |
| 18380961 | Method for Monitoring and Control of a Wastewater Process Stream | October 2023 | August 2025 | Allow | 22 | 2 | 0 | Yes | No |
| 18487393 | CONDENSED POLYCYCLIC CONJUGATED POLYMERS AND THEIR USE FOR BIOLOGICAL DETECTION | October 2023 | January 2025 | Allow | 15 | 2 | 0 | No | No |
| 18477728 | SIMPLIFIED BIOSAMPLE PROCESSING FOR LC-MS/MS | September 2023 | June 2025 | Abandon | 21 | 1 | 0 | No | No |
| 18474008 | HYDROGEN-BONDED ORGANIC FRAMEWORK NANOSHEET, PREPARATION METHOD AND APPLICATION THEREOF | September 2023 | November 2023 | Allow | 2 | 0 | 0 | No | No |
| 18471497 | System and Method for Background Removal in Spectrometry System | September 2023 | March 2026 | Abandon | 30 | 2 | 0 | Yes | No |
| 18471025 | METHYLATION MARKERS AND TARGETED METHYLATION PROBE PANEL | September 2023 | May 2025 | Allow | 19 | 0 | 0 | No | No |
| 18465669 | MULTIFUNCTIONAL MAGNETIC TAGS FOR MUD LOGGING | September 2023 | March 2025 | Allow | 18 | 0 | 0 | No | No |
| 18241381 | DETECTION AND QUANTIFICATION OF GLYCOSYLATED PEPTIDES | September 2023 | August 2024 | Allow | 12 | 0 | 0 | No | No |
| 18460474 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS AND USES THEREOF | September 2023 | December 2024 | Allow | 16 | 4 | 0 | Yes | No |
| 18454838 | METHOD TO ANALYZE COMPOUNDS IN BIOLOGICAL SAMPLES | August 2023 | July 2024 | Allow | 11 | 0 | 0 | Yes | No |
| 18454159 | BIOMARKERS FOR DIAGNOSING NON-ALCOHOLIC STEATOHEPATITIS (NASH) OR HEPATOCELLULAR CARCINOMA (HCC) | August 2023 | November 2024 | Allow | 14 | 1 | 0 | No | No |
| 18235941 | METHOD FOR ANALYZING MICROORGANISM | August 2023 | February 2026 | Allow | 30 | 2 | 0 | Yes | No |
| 18235943 | METHOD FOR ANALYZING MICROORGANISM | August 2023 | September 2024 | Allow | 13 | 0 | 0 | No | No |
| 18236144 | METHOD OF SAMPLE PREPARATION FOR MALDI AND AUTOMATED SYSTEM THEREFOR | August 2023 | August 2024 | Allow | 12 | 0 | 0 | Yes | No |
| 18546137 | MALDI-MS METHOD, PHOTO-SENSITIVE MALDI MATRIX COMPOSITE AND PHOTO-CAGED MALDI MATRIX COMPOUND FOR USE IN SAID METHOD AND RESPECTIVE USES | August 2023 | February 2026 | Allow | 30 | 0 | 0 | No | No |
| 18209074 | SYNCHRONIZATION OF ION GENERATION WITH CYCLING OF A DISCONTINUOUS ATMOSPHERIC INTERFACE | June 2023 | January 2025 | Allow | 19 | 1 | 0 | No | No |
| 18208116 | SYSTEMS AND METHODS FOR SAMPLE ANALYSIS USING SWABS | June 2023 | June 2024 | Allow | 12 | 0 | 0 | Yes | No |
| 18321542 | METHODS FOR DETECTING AAV | May 2023 | June 2024 | Allow | 13 | 0 | 0 | No | No |
| 18313183 | MULTI-STEP KINETIC IMMUNOASSAY SYSTEMS AND METHODS | May 2023 | January 2024 | Allow | 9 | 1 | 0 | No | No |
| 18308813 | PEPTIDE QUANTITATION ASSAY FOR DIFFERENTIATING FULL-LENGTH HIGH MOLECULAR WEIGHT KININOGEN (HMWK) ANDCLEAVED HMWK | April 2023 | June 2024 | Allow | 14 | 0 | 0 | Yes | No |
| 18139741 | SYNTHETIC HUMAN CELL MIMIC HYDROGEL PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | April 2023 | October 2023 | Allow | 6 | 1 | 0 | No | No |
| 18307135 | AUTOSAMPLER SAMPLE AND SAMPLE RACK IDENTIFICATION | April 2023 | January 2025 | Allow | 20 | 1 | 0 | No | No |
| 18306176 | SENSORS AND SENSING METHODS | April 2023 | December 2024 | Abandon | 20 | 1 | 0 | No | No |
| 18304915 | Screening Kit and Diagnosis System for Primary Aldosteronism | April 2023 | August 2023 | Allow | 4 | 0 | 0 | No | No |
| 18301279 | METHODS FOR ANALYZING BODY FLUID PROTEOME | April 2023 | June 2024 | Allow | 14 | 2 | 0 | No | No |
| 18032020 | BINDING ASSAYS INVOLVING A PLURALITY OF SYNTHETIC COMPOUNDS, TARGETS, AND COUNTER TARGETS | April 2023 | November 2025 | Abandon | 32 | 3 | 0 | Yes | No |
| 18123753 | Tandem Mass Tag Multiplexed Quantitation of Post-Translational Modifications of Proteins | March 2023 | June 2024 | Allow | 15 | 0 | 0 | Yes | No |
| 18122010 | DEVICE AND METHODS FOR QUANTIFYING ANALYTES INTRODUCTION | March 2023 | August 2025 | Allow | 29 | 4 | 0 | Yes | No |
| 18175066 | USE OF LC-MS/MS TO QUANTITATE PROTEIN BIOMARKERS | February 2023 | August 2024 | Allow | 18 | 1 | 0 | Yes | No |
| 18112671 | DETECTION CHIP, USING METHOD FOR THE SAME, AND REACTION SYSTEM | February 2023 | December 2024 | Allow | 22 | 1 | 0 | No | No |
| 18111336 | RAPID NATIVE SINGLE CELL MASS SPECTROMETRY | February 2023 | May 2024 | Allow | 15 | 0 | 0 | No | No |
| 18165865 | ISOTYPING IMMUNOGLOBULINS USING ACCURATE MOLECULAR MASS | February 2023 | May 2024 | Allow | 15 | 0 | 0 | No | No |
| 18154401 | METHODS FOR CHARACTERIZING DISULFIDE BONDS | January 2023 | January 2024 | Allow | 12 | 0 | 0 | Yes | No |
| 18153738 | METHOD FOR EVALUATING DATA FROM MASS SPECTROMETRY, MASS SPECTROMETRY METHOD, AND MALDI-TOF MASS SPECTROMETER | January 2023 | September 2024 | Allow | 20 | 1 | 0 | No | No |
| 18093939 | FILTRATION SAMPLING DEVICES | January 2023 | May 2023 | Allow | 5 | 1 | 1 | Yes | No |
| 18147248 | KIND OF METHOD FOR DETECTING SIALOGLYCOSYL CASEIN GLYCOMACROPEPTIDE | December 2022 | December 2025 | Allow | 36 | 1 | 0 | No | No |
| 18088946 | SYSTEM AND METHOD FOR PROTEIN CORONA SENSOR ARRAY FOR EARLY DETECTION OF DISEASES | December 2022 | January 2024 | Allow | 13 | 0 | 0 | Yes | No |
| 18145602 | METHODS FOR THE DETECTION AND TREATMENT OF PROSTATE CANCER | December 2022 | February 2026 | Allow | 37 | 0 | 0 | No | No |
| 18069458 | FORMULATION FOR TOTAL AND DIFFERENTIAL COUNTING OF LEUKOCYTES IN LIQUID MEDIUM AND METHOD OF MAKING AND USING SAME | December 2022 | July 2025 | Allow | 31 | 0 | 0 | No | No |
| 18069502 | METHYLATION MARKERS AND TARGETED METHYLATION PROBE PANEL | December 2022 | March 2023 | Allow | 3 | 0 | 0 | No | No |
| 18079644 | Tracer Analysis | December 2022 | July 2024 | Allow | 19 | 0 | 0 | No | No |
| 18063975 | RAPID IDENTIFICATION AND SEQUENCE ANALYSIS OF INTACT PROTEINS IN COMPLEX MIXTURES | December 2022 | March 2025 | Allow | 27 | 2 | 0 | Yes | No |
| 17928893 | AMINO-SUBSTITUTED CHROMENOQUINOLINE-BASED FLUORESCENT MARKER, AND PREPARATION AND USE THEREOF | November 2022 | August 2025 | Allow | 32 | 1 | 0 | No | No |
| 18059404 | METHOD FOR DISCRIMINATING A MICROORGANISM | November 2022 | April 2024 | Allow | 17 | 1 | 0 | No | No |
| 18070451 | COMPOUNDS FOR MARKING LIQUIDS | November 2022 | February 2026 | Abandon | 38 | 0 | 1 | No | No |
| 17927025 | METHOD AND APPARATUS FOR ANALYZING BIOCHIP IMAGE, COMPUTER DEVICE, AND STORAGE MEDIUM | November 2022 | February 2026 | Allow | 39 | 2 | 0 | No | No |
| 17991366 | REAGENT FOR MASS SPECTROMETRY | November 2022 | February 2026 | Allow | 39 | 2 | 0 | No | No |
| 17990360 | CYTOMETRIC DEVICE HEMATOLOGY REFERENCE COMPOSITION | November 2022 | April 2023 | Allow | 5 | 1 | 0 | No | No |
| 17975288 | Methods and Systems for Measuring Progesterone Metabolites | October 2022 | January 2026 | Abandon | 39 | 1 | 0 | No | No |
| 17921165 | METHODS OF DETECTING UBE3A PROTEIN | October 2022 | July 2025 | Allow | 32 | 0 | 0 | No | No |
| 17972535 | BTEX METABOLITES DERIVATIZATION KIT AND COMPOSITION | October 2022 | August 2024 | Allow | 21 | 1 | 0 | No | No |
| 17919496 | ISOBARIC STABLE ISOTOPE-CONTAINING PHOSPHORYLATED PROTEIN LABELING REAGENT, AND PREPARATION METHOD AND APPLICATION THEREOF | October 2022 | July 2025 | Allow | 33 | 0 | 0 | No | No |
| 17960702 | METHODS OF CHARACTERIZING CONDENSATE-ASSOCIATED CHARACTERISTICS OF COMPOUNDS AND USES THEREOF | October 2022 | October 2024 | Allow | 25 | 1 | 0 | No | No |
| 17995452 | METHODS AND COMPOSITIONS TO DETERMINE THE QUALITY OF RED BLOOD CELL UNITS | October 2022 | January 2026 | Abandon | 39 | 1 | 0 | No | No |
| 17937170 | SYSTEMS AND METHODS FOR GLYCOPEPTIDE CONCENTRATION DETERMINATION, NORMALIZED ABUNDANCE DETERMINATION, AND LC/MS RUN SAMPLE PREPARATION | September 2022 | September 2025 | Allow | 35 | 1 | 1 | No | No |
| 17955214 | PEPCON PROTEOMICS STANDARDS AND METHODS OF USE | September 2022 | June 2024 | Allow | 20 | 2 | 0 | Yes | No |
| 17952304 | METHOD FOR CHARACTERIZING GRAPHENE ON PLATINUM SUBSTRATE | September 2022 | June 2023 | Allow | 9 | 1 | 0 | No | No |
| 17762425 | METHODS AND SYSTEMS FOR DETECTING AND QUANTIFYING LARGE NUMBER OF MOLECULE BIOMARKERS FROM A BODY FLUID SAMPLE | September 2022 | July 2025 | Allow | 40 | 1 | 0 | No | No |
| 17910768 | BIOMARKERS FOR CLEAR CELL RENAL CELL CARCINOMA | September 2022 | March 2026 | Allow | 42 | 1 | 0 | No | No |
| 17930340 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | September 2022 | June 2024 | Allow | 21 | 3 | 0 | Yes | No |
| 17939760 | Optics Collection and Detection System and Method | September 2022 | April 2024 | Allow | 19 | 1 | 0 | No | No |
| 17930324 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | September 2022 | March 2024 | Abandon | 18 | 2 | 0 | Yes | No |
| 17903229 | Magnetic Selector And Systems Incorporating Same | September 2022 | September 2025 | Allow | 36 | 1 | 0 | No | No |
| 17929369 | Automated Method For Performing An Assay | September 2022 | July 2024 | Allow | 23 | 1 | 0 | No | No |
| 17929350 | Fluidic Test Cassette | September 2022 | March 2024 | Allow | 18 | 0 | 0 | No | No |
| 17823360 | METHOD OF USING CHEMICAL TAGS TO IMPROVE THE IDENTIFICATION, QUANTIFICATION AND SPATIAL LOCALIZATION OF COMPONENTS IN A SAMPLE | August 2022 | February 2024 | Allow | 17 | 0 | 0 | No | No |
| 17802250 | CANCER DIAGNOSIS USING RAMAN SIGNAL OF URINE | August 2022 | August 2025 | Allow | 36 | 1 | 0 | Yes | No |
| 17887532 | DEVICE AND METHOD FOR COMPREHENSIVE CHARACTERIZATION, ANALYSIS, HETERO-GENITY AND PURITY QUANTIFICATION OF EXTRACELLULAR VESICLES | August 2022 | September 2025 | Allow | 37 | 0 | 0 | No | No |
| 17797284 | METHOD FOR ASSISTING DETECTION OF NON-ALCOHOLIC STEATOHEPATITIS | August 2022 | December 2025 | Allow | 40 | 1 | 1 | Yes | No |
| 17875765 | AMINO ACID ANALYSIS METHOD | July 2022 | September 2025 | Allow | 37 | 1 | 0 | No | No |
| 17862990 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | July 2022 | November 2023 | Allow | 16 | 1 | 0 | Yes | No |
| 17608285 | DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS ASSOCIATED WITH ALTERED METABOLIC PATHWAYS | June 2022 | February 2026 | Abandon | 52 | 1 | 0 | No | No |
| 17841098 | METHOD TO CORRECT ION SOURCE INEFFICIENCIES MAKES SAMPLE-TO-SAMPLE NORMALIZATION POSSIBLE | June 2022 | January 2024 | Allow | 19 | 0 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner XU, XIAOYUN.
With a 36.8% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 24.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner XU, XIAOYUN works in Art Unit 1797 and has examined 837 patent applications in our dataset. With an allowance rate of 65.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.
Examiner XU, XIAOYUN's allowance rate of 65.1% places them in the 26% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by XU, XIAOYUN receive 2.26 office actions before reaching final disposition. This places the examiner in the 63% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by XU, XIAOYUN is 34 months. This places the examiner in the 42% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +28.5% benefit to allowance rate for applications examined by XU, XIAOYUN. This interview benefit is in the 76% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 24.1% of applications are subsequently allowed. This success rate is in the 35% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 17.0% of cases where such amendments are filed. This entry rate is in the 19% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 40.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 39% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 49.1% of appeals filed. This is in the 14% percentile among all examiners. Of these withdrawals, 38.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 62.1% are granted (fully or in part). This grant rate is in the 67% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 2.9% of allowed cases (in the 79% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.7% of allowed cases (in the 58% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.